Clinical Trials Browser

Hematologic Diseases × Other hematologic neoplasm × Clear all

NCT02158858 2026-06-04

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

MyeloidOther hematologic neoplasmOther neoplasm

Bone Marrow Diseases, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Precancerous Conditions, Preleukemia, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases, Primary Myelofibrosis

NCT00001620 2026-05-29

Screening for Hematology Branch Protocols

Enrolling by invitation

10,000 enrolled

Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT03246906 2026-05-14

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Phase 2 Terminated

150 enrolled 18 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematologic Diseases, Hodgkin Disease, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT06795815 2026-05-07

OHGW-ACP

Phase NA Recruiting

75 enrolled

LymphoidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphoma, Neoplasms

NCT04996875 2026-05-05

APEX

Phase 2 Recruiting

140 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Hypersensitivity, Immune Complex Diseases, Immune System Diseases, Leukemia, Leukemia, Mast-Cell, Leukemia, Myeloid, Mastocytosis, Myeloproliferative Disorders, Neoplasms, Neoplasms by Site, Neoplasms, Connective Tissue, Skin Diseases, Soft Tissue Neoplasms, Urticaria Pigmentosa, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Mastocytosis, Systemic

Clinical Trials

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

Screening for Hematology Branch Protocols

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

OHGW-ACP

APEX

VENAZA-5S

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

BRUIN CLL-321

Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.

COMPLHEMATO

BRUIN-CLL-314

QUATRO-APL

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

CHIS

CLOVER-WaM

ACCESS

OPTIC

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

HORIZONS

Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

OPTIMIZE

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

BRUIN CLL-322

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

BRUIN CLL-313

AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission

Bone Marrow Grafting for Leukemia and Lymphoma

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

PAIA-Haplo

BMT-CARE

HEME Home Transfusion Program

Muscle Dysfunction in Patients With Haematological Diseases

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT)

Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer

CYNK001AML01

Evaluation of ClearLLab LS Screening Panel

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth

Myeloproliferative Neoplasms (MPNs) Patient Registry